Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06119243 · ClinicalTrials.gov registry record

Multicenter Evaluation of Near Vision and Outdoor Time in Kids Study

A clinical trial of Myopia, sponsored by The University of New South Wales.

Recruiting
Registry status
230
Enrollment target
5
Study locations

NCT06119243: Recruiting study of Myopia, sponsored by The University of New South Wales.

NCT06119243 is a study of Myopia that is actively recruiting participants, run by The University of New South Wales. The registered enrollment target is 230 participants, below the 265-participant average among 90 other Myopia trials with a reported enrollment target (13% lower). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06119243, a study of Myopia, is actively recruiting participants, sponsored by The University of New South Wales.

RECRUITING
Registry status
230 participants
Enrollment target
5
Study locations

Study Summary

Currently, optical and pharmacological interventions have been developed to prevent the progression of childhood myopia. However, no myopia control strategy has been shown to have complete efficacy in controlling myopia progression in children. One possible reason is that risk factors contributing to the development of myopia were not controlled in previous clinical studies including time outdoors and near vision behaviour. This study aims to quantify time spent outdoors and near vision behavior in myopic children and its impact on myopia control efficacy. The outcomes of this study will guide clinicians on risk management and improve responses to existing treatments for progressive myopia.

Primary Outcome

Duration during near tasks

Conditions Studied

Myopia

Interventions

  • DEVICE Vivior

Study Locations (5)

California

  • School of Optometry, University of California, Berkeley - Berkeley

Massachusetts

  • New England College of Optometry - Boston

New York

  • State University of New York (SUNY), College of Optometry - New York

New South Wales

  • School of Optometry and Vision Science, UNSW - Sydney

Queensland

  • Optometry and Vision Science, Queensland University of Technology - Kelvin Grove

Trial Details

FieldValue
Enrollment Target 230 participants
Start Date 2023-03-21
Est. Completion 2026-12-31
The University of New South Wales

2 total trials

What NCT06119243 shows while recruiting

NCT06119243 is an observational study that tracks outcomes without assigning an intervention. The registered 230 participants enrollment target is mid-sized for trials with a published cap, below the 265-participant average among 90 other Myopia trials with a reported enrollment target (13% lower).

The record links to 1 condition, with Myopia appearing as the primary indexed condition, and to 1 intervention - of which Vivior is the first listed.

NCT06119243 lists 5 locations in 5 states (California, Massachusetts, New York).

Frequently Asked Questions

What is clinical trial NCT06119243 about?

NCT06119243 is a clinical study titled "Multicenter Evaluation of Near Vision and Outdoor Time in Kids Study". Currently, optical and pharmacological interventions have been developed to prevent the progression of childhood myopia. However, no myopia control strategy has been shown to have complete efficacy in controlling myopia progression in children. One possible reason is that risk factors contributing t...

What is the current status of trial NCT06119243?

This trial is currently recruiting. The enrollment target is 230 participants. The study started on 2023-03-21. Estimated completion is 2026-12-31.

What conditions does trial NCT06119243 study?

This clinical trial studies the following conditions: Myopia.

What interventions are being tested in trial NCT06119243?

The interventions under investigation include: Vivior (DEVICE).

Who is sponsoring clinical trial NCT06119243?

This trial is sponsored by The University of New South Wales, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06119243 being conducted?

This trial has 5 study locations across California, Massachusetts, New York, New South Wales, Queensland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Myopia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06119243's enrollment target sits among peer trials

230 22nd of 90 higher than 69 of 90 other Myopia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Myopia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02710253 · 230 participants · Phase 2

    Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy

  • NCT02777879 · 230 participants

    Lung Microbiome and Inflammation in Early COPD

  • NCT03824483 · 230 participants · Phase 2

    Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL)

  • NCT03833622 · 230 participants · NA

    Shared Decision Making to Improve Goals of Care in the ED

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT06119243

Source: ClinicalTrials.gov NCT06119243, the US trial registry maintained by the National Library of Medicine. NCT06119243 (mid enrollment · multi site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.